Response to Comments: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia

This document is a response-to-comments notice for MolDX Local Coverage Determination L39262 and only records administrative dates: comment period (04/28/2022–06/11/2022), notice begin (04/13/2023), and effective date (05/28/2023). It does not contain clinical coverage criteria, indications, limitations, or frequency limits for testing in this text.

"This document records the comment period for MolDX LCD L39262 (04/28/2022–06/11/2022) and the notice/effective dates (notice begins 04/13/2023; effective 05/28/2023)."

Sign up to see full coverage criteria, indications, and limitations.